This is a guest post by Hector Perez, a KCA Ambassador. Hector was diagnosed with kidney cancer in 2006. After my kidney cancer diagnosis, I didn’t change any of my fitness or nutrition habits. I…
A nephrectomy is surgery to remove all or part of a kidney, but when someone has surgery to remove a kidney tumor that has metastasized (spread) to other areas, the name for the procedure is called a cytoreductive nephrectomy. In years past, this procedure provided the best option to prolong survival for people with metastatic renal cell carcinoma (mRCC) because no effective pharmaceutical treatments existed for this patient group.
The 2023 International Kidney Cancer Symposium: Europe, taking place in Edinburgh, Scotland on April 21-22, will feature three special lectures by prominent experts in kidney cancer. Register now.
By D’Ann George, PhD, Medical Writer While Chris Jonas grappled with the discovery of new tumors from her kidney cancer, Hurricane Florence was flinging its fury at her hometown of Morehead City near the coast…
This is a guest post by Hector Perez, a KCA Ambassador. It’s been 12 years since I was diagnosed with renal cell carcinoma (RCC). There are still several nodules; however, they are under control and…
This is a guest post by Frances Mora, 39. Frances lives in Miami. We are quickly approaching the one-year mark, when I received the shock of a lifetime. I had just given birth to my…
This is a guest post by Rachel O’Leary. In March of 2022 I was going to see my orthopedist for chronic lower back pain that I had been having on my right side. This is…
By D’Ann George, PhD, Medical Writer We rounded up a few research highlights from the 2023 ASCO Genitourinary Cancers Symposium (ASCO GU), held recently in San Francisco, California. Kidney cancer guidelines updates Dr. Shuchi Gulati…
A new way to scan and image renal masses has the potential to accurately determine if a renal mass is cancerous or benign before a patient needs to have surgery. The phase 3 ZIRCON trial…
By D’Ann George, PhD, Medical Writer When talking to people about clinical trials, Dr. Chung-Han Lee, an oncologist and kidney cancer expert at Memorial Sloan Kettering Cancer Center in New York, hears many of the…